Regulation of macrophage interleukin-6 (IL-6) and IL-10 expression by prostaglandin E2: The role of p38 mitogen-activated protein kinase

Journal of Interferon and Cytokine Research

Volumn 20, Issue 3, 2000, Pages 291-298

  Williams, Joy A ^a   Pontzer, Carol H ^b   Shacter, Emily ^a,c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; SYNAPTOPHYSIN;

ANIMAL CELL; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RNA PURIFICATION;

ANIMALS; DINOPROSTONE; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TIME FACTORS;

ANIMALIA; MURINAE;

EID: 0034067471     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312423     Document Type: Article

References (39)

1. 2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol. 150, 5321-5329.
2. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113.
3. 2 regulation of the immune response. Adv. Prostaglandin Thromboxane Leukotriene Res. 22, 101-111.
4. 2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263, 5380-5384.
5. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779.
6. 2 by LPS-stimulated rat bone marrow macrophages after thermal injury: effect of indomethacin. Inflammation 18, 175-185.
7. 7. MARCINKIEWICZ, J. (1991). In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6. Cytokine 3, 327-332.
8. 8. SHACTER, E., ARZADON, G.K., and WILLIAMS, J. (1992). Elevation of IL-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood 80, 194-202.
9. 9. PLATZER, C., MEISEL, C., VOGT, M., PLATZER, M., and VOLK, H.D. (1995). Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7, 517-523.
10. 2. J. Exp. Med. 180, 2365-2370.
11. 2. J. Biol. Chem. 272, 25693-25699.
12. 12. SUNG, S.J., and WALTERS, J.A. (1991). Increased cyclic AMP levels enhance IL-1α and IL-1β mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J. Clin. Invest. 88, 1915-1923.
13. 13. WEINSTEIN, S.L., SANGHERA, J.S., LEMKE, K., DEFRANCO, A.L., and PELECH, S.L. (1992). Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267, 14955-14962.
14. 14. FOEY, A.D., PARRY, S.L., WILLIAMS, L.M., FELDMANN, M., FOXWELL, B.M.J., and BRENNAN, F.M. (1998). Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-α: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160, 920-928.
15. 15. LEE, J.C., LAYDON, J.T., McDONNELL, P.C., GALLAGHER, T.F., KUMAR, S., GREEN, D., McNULTY, D., BLUMENTHAL, M.J., HEYS, J.R., LANDVATTER, S.W., STRICKLER, J.E., McLAUGHLIN, M.M., SIEMENS, I.R., FISHER, S.M., LIVI, G.P., WHITE, J.R., ADAMS, J.L., and YOUNG, P.R. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
16. 16. GALLAGHER, T.F., SEIBEL, G.L., KASSIS, S., LAYDON, J.T., BLUMENTHAL, M., LEE, J.C., LEE, D., BOEHM, J.C., FIER-THOMPSON, S.M., ABT, J.W., SORESON, M.E., SMIETHANA, J.M., HALL, R.F., GARIGIPATI, R.S., BENDER, P.E., ERHARD, K.F., KROG, A.J., HOFMANN, G.A., SHELDRAKE, P.L., McDONNELL, P.C., KUMAR, S., YOUNG, P.R., and ADAMS, J.L. (1997). Regulation of stress-induced cytokine production by pyridinylimidazoles, inhibition of CSBP kinase. Bioorg. Med. Chem. 5, 49-64.
17. 17. YOUNG, P.R., McLAUGHLIN, M.M., KUMAR, S., KASSIS, S., DOYLE, M.L., McNULTY, D., GALLAGHER, T.F., FISHER, S., McDONNELL, P.C., CARR, S.A., HUDDLESTON, M.J., SEIBEL, G., PORTER, T.G., LIVI, G.P., ADAMS, J.L., and LEE, J.C. (1997). Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J. Biol. Chem. 272, 12116-12121.
18. 18. RIDLEY, S.H., SARSFIELD, S.J., LEE, J.C., BIGG, H.F., CAWSTON, T.E., TAYLOR, D.J., DEWITT, D.L., and SAKLATVALA, J. (1997). Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase. J. Immunol. 158, 3165-3173.
19. 19. DE CESARIS, P., STARACE, D., RICCIOLI, A., PADULA, F., FILIPPINI, A., and ZIPARO, E. (1998). Tumor necrosis factor-α induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J. Biol. Chem. 273, 7566-7571.
20. 20. BEYAERT, R., CUENDA, A., VANDEN BERGHE, W., PLAISANCE, S., LEE, J.C., HAEGEMAN, G., COHEN, P., and FIERS, W. (1996). The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis in response to tumor necrosis factor. EMBO J. 15, 1914-1923.
21. 21. BERGHE, W.V., PLAISANCE, S., BOONE, E., DE BOSSCHER, K., SCHMITZ, M.L., FIERS, W., and HAEGEMAN, G. (1998). p38 and extracellular signal-related kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273, 3285-3290.
22. 22. MIYAZAWA, K., MORI, A., MIYATA, H., AKAHANE, M., AJISAWA, Y., and OKUDAIRA, H. (1998). Regulation of interleukin-1b-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273, 24832-24838.
23. 2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265, 16737-16740.
24. 24. KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W., and HERSCHMAN, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxy genase homologue. J. Biol. Chem. 266, 12866-12872.
25. 25. RIESE, J., HOFF, T., NORDHOFF, A., DEWITT, D.L., RESCH, K., and KAEVER, V. (1994). Transient expression of prostaglandin endoperoxide synthease-2 during mouse macrophage activation. J. Leukocyte Biol. 55, 476-482.
26. 26. POULIOT, M., BAILLARGEON, J., LEE, J.C., CLELAND, L.G., and JAMES, M.J. (1997). Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J. Immunol. 158, 4930-4937.
27. 27. GUAN, Z., BUCKMAN, S.Y., PENTLAND, A.P., TEMPLETON, D.J., and MORRISON, A.R. (1998). Induction of cyclooxygenase-2 by the activated MEKK1 → SEK/MKK4 → p38 mitogen-activated protein kinase pathway. J. Biol. Chem. 273, 12901-12908.
28. 28. DEAN, J.L.E., BROOK, M., CLARK, A.R., and SAKLATVALA, J. (1999). p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274, 264-269.
29. 29. SHACTER, E., BEECHAM, E.J., COVEY, J.M., KOHN, K.W., and POTTER, M. (1988). Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis 9, 2297-2304.
30. 2 secretion from peritoneal macrophages by polymers of albumin. Blood 82, 2853-2864.
31. 31. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M., and O'GARRA, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147, 3815-3822.
32. 32. LIN, A., MINDEN, A., MARTINETTO, H., CLARET, F.X., LANGE-CARTER, C., MERCURIO, F., JOHNSON, G.L., and KARIN, M. (1995). Identification of a dual specificity kinase that activates the Jun kinase and p38-Mpk2. Science 268, 286-290.
33. 33. MANTHEY, C.L., WANG, S., KINNEY, S.D., and YAO, Z. (1998). SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J. Leukocyte Biol. 64, 409-417.
34. 2 in a murine model of inflammation. Possible role of cyclooxygenase-2. Proc. Natl. Acad. Sci. USA 93, 4885-4890.
35. 35. ANDERSON, G.D., HAUSER, S.D., McGARITY, K.L., BREMER, M.E., ISAKSON, P.C., and GREGORY, S.A. (1996). Selective inhibition of cyclooxygenase (Cox)-2 reverses inflammation and expression of Cox-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97, 2672-2679.
36. 36. BADGER, A.M., BRADBERR, J.N., VOTTA, B., LEE, J.C., ADAMS, J.L., and GRISWOLD, D.E. (1996). Pharmocological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279, 1453-1461.
37. 37. KOPRAK, S., STARUCH, M.J., and DUMONT, F.J. (1999). A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signalling and preferential inhibition of IL-10 production. Cell. Immunol. 192, 87-95.
38. 2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression. Infect. Immun. 57, 2837-2841.
39. 39. GOODWIN, J.S. (1991). Are prostaglandins proinflammatory, anti-inflammatory, both or neither? J. Rheumatol. 18(Suppl 28), 26-29.